Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 61, 2001 - Issue 6
Submit an article Journal homepage
101
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma

E Eldrup Division of Endocrinology, Department of Internal Medicine E, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
,
N Clausen Department of Pediatrics, Aarhus University Hospital, Skejby Hospital, Aarhus, Denmark;
,
B Scherling Section of Clinical Hematology and Oncology, Pediatric Clinic II, Juliane Marie Center, UniversityHospital, Rigshospitalet,Copenhagen,Denmark
&
K Schmiegelow Division of Endocrinology, Department of Internal Medicine E, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
Pages 479-490 | Published online: 08 Jul 2009

  • Brodeur GM, Castleberry RP. Neuroblastoma. In: PIZZO PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven; 1997. p. 761-97.
  • Sawada T. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors (Editorial). Ped Hematol Oncol 1997; 14: 291-3.
  • Schweisguth O. Excretion of catecholamine metabolites in urine of neuroblastoma patients. J Pediatr Surg l968;3: 118-20.
  • LaBrosse EH, Com-Nougué C, Zucker JM, Comoy E, Bohuon C, Lemerle J, Schweisguth O. Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 1980; 40: 1995-2001.
  • Pritchard J, Bames J, Germond S, Hartman O, Kraker J de, Lewis I, Lockwood L, Wallendszus K. Stage and urinary catecholamine metabolite excretion in neuroblastoma (Letter). Lancet 1989; II: 514-5.
  • Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localized but not with metastatic neuroblastoma. Eur J Cancer 1992; 28A: 1950-4.
  • Tuchman M, Ramnaraine MLR, Woods WG, Krivit W. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 1987; 79: 203-5.
  • Lucas K, GuIa MJ, Knisely AS, Virgi MA, Wollman M, Blatt J. Catecholamine metabolites in ganglioneuroma. Med Pediatr Oncol 1994; 22: 240-3.
  • Tang QM, Xu XR, Shi YQ, Jin BX. Determination of serum catecholamine metabolites in neuroblas-toma by high performance liquid chromatography with electrochemical detection. Biomed Chromatogr 1986; 1:7-11.
  • Gahr M, Hunneman DH. The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children. Eur J Pediatr 1987; 146; 489-93.
  • Von Studnitz W, Käser H, Sjoerdsma A. Spectrum of amine biochemistry in patients with neuroblastoma. N Engl J Med 1963; 269: 232-5.
  • Sourkes TL, Denton RL, Murphy GF, Chavez B, Cyr SS. The excretion of dihydroxyphenylalanine, dopamine, and dihydroxyphenylacetic acid in neuroblastoma. Pediatrics 1963; 31: 660-8.
  • Helson L, Johnson GA, Smith R. Dopa metabolism in neuroblastoma. Med Pediatr Oncol 1980; 8:317-22.
  • Alvarado CS, Camp VM, Faraj BA, Kim TH, Ragab AH. Plasma DOPA and catecholamines in the diagnosis and follow-up of children with neuroblastoma. Am J Pediatr Hematol Oncol 1985; 7: 221-7.
  • Boomsma F, Ausema L, Hakvoort-Cammel FGA, Oosterom R, Man in 't Veld AJ, Krenning EP, Hahlen K, Schalekamp MADH. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumor markers in diagnosis and follow-up of neuroblastoma. Eur J Cancer Clin Oncol 1989; 25: 1045-52.
  • Itoh T, Ohmori K. Biosynthesis and storage of catecholamines in pheochromocytoma and neuroblastoma cells. J Lab Clin Med 1973; 81: 887-96.
  • Waymire JC, Gilmer-Waymire K. Adrenergic enzymes in cultured mouse neuroblastoma: absence of detectable aromatic-L-amino-acid decarboxylase. J Neurochem 1978; 31: 693-8.
  • Eldrup E, Hetland ML, Christensen NJ. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans. Eur J Clin Invest 1994; 24: 205-11.
  • Ino M, Cole GM, Timiras PS. Tyrosine hydroxylase and monoamine oxidase-A activity increases in differentiating human neuroblastoma after elimination of dividing cells. Brain Res 1986; 395: 120-3.
  • Evans EA, D'Angio GJ, Randolph JA. A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer 1971; 27: 374-8.
  • Eldrup E, Richter EA, Christensen NJ. Dopa, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle DOPA. Am J Physiol Endocrinol Metab 1989; 256: E284-7.
  • Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ. Cerebrospinal fluid and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease. Acta Neurol Scand 1995; 92: 116-21.
  • Holly JM, Patel N. The assay of 4-hydroxy3-methoxymandelic acid in urine by HPLC with electrochemical detection using bonded-phase silicasorbents for rapid, simple and selective extraction. Ann Clin Biochem 1986; 23: 447-52.
  • Gotelli GR, Kabra PM. Simultaneous determination of urinary vanillylmandelic acid, S-hydroxyindoleacetic acid and homovanillic acid by liquid chromatography. J Chromatogr 1988; 428: 147-51.
  • Tuchman M, Morris CL, Ramnaraine BS, Bowers LD, Krivit W. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections. Pediatrics 1985; 75: 324-8.
  • Ikeda H, Suzuki N, Takahashi A, Kuroiwa M, Matsuyama S. 3,4-dihydroxy-phenylalanine (DOPA) metabolism in screening-detected and non-screening-detected neuroblastoma. Pediatr Hematol Oncol 1996; 13: 21-32.
  • Fitzgibbon MC, Tormey WP. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis. Ann Clin Biochem 1994; 31: 1-11.
  • Cole M, Craft AW, Parker L, Bell S, Seviour JA,McGiIl AC, Dale G. Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults. Clin Chim Acta 1995:236:19-32.
  • Eldrup E, Richter EA. Dopa, dopamine and dopac concentrations in the rat gastrointestinal tract decrease during fasting. Am J Physiol Endocrinol Metab 2000; 279: E815-22.
  • Eisenhofer G, Rundquist B, Friberg P. Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. Am J Physiol (Regulatory Integrative Comp Physiol) 1998; 274: R626-34.
  • Eldrup E, Mø11er SE, Andreasen J, Christensen NJ. Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid. Clin Sci 1997; 92: 423-30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.